Agreement - January 21, 2026
Sigrid Therapeutics enters collaboration to commercialize SiPore
The company has entered into an exclusive global licensing and research collaboration with a multinational consumer health company to expand the SiPore technology platform into consumer oral health through a partner-led approach.
Agreement - January 20, 2026
OnDosis enters collaboration with Diamond Therapeutics
The two companies have entered into an agreement regarding the use of the OnDosis drug delivery platform, the Dosage Manager, in Diamond’s psychoactive low-dose psilocybin programs.
Biotech Business - January 20, 2026
Affibody carries out fully guaranteed rights issue
The Board of Directors of the company has resolved to carry out a fully guaranteed rights issue of SEK 307 million.
Biotech Business - January 20, 2026
AAX Biotech and Vascurie collaborate
AAX Biotech will leverage its Seqitope platform and automation infrastructure to accelerate antibody characterization, driving faster, data-driven insights across drug discovery and development.
Funding - January 19, 2026
These 11 Swedish projects receive grants from the Proof-of-Concept program
The grants grants from Knut and Alice Wallenberg Foundation and SciLifeLab's Proof-of-Concept program aim to strengthen the path from academic research to innovation and commercial application in life science.
Global report - January 18, 2026
Trump announces new tariffs against Europe
In a post on Truth Social, US President Trump said additional 10% import tariffs would take effect on February 1, 2026 on goods from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland and Great Britain. Those tariffs would increase to 25% on June 1, 2026 and would continue until a deal was reached for the […]
